Specific Polo-like kinase 1 (PLK1) expression in Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) suggests an intact immune surveillance program.
出版年份 2023 全文链接
标题
Specific Polo-like kinase 1 (PLK1) expression in Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) suggests an intact immune surveillance program.
作者
关键词
-
出版物
AMERICAN JOURNAL OF PATHOLOGY
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2023-11-04
DOI
10.1016/j.ajpath.2023.10.008
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- 3D analyses reveal T cells with activated nuclear features in T-cell/histiocyte-rich large B-cell lymphoma
- (2022) Aresu Sadeghi Shoreh Deli et al. MODERN PATHOLOGY
- FOXP3 expression diversifies the metabolic capacity and enhances the efficacy of CD8 T cells in adoptive immunotherapy of melanoma
- (2022) Enrique Conde et al. MOLECULAR THERAPY
- Immune infiltrate diversity confers a good prognosis in follicular lymphoma
- (2021) Anna-Maria Tsakiroglou et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- CD8+ Regulatory T Cell – A Mystery to Be Revealed
- (2021) Shruti Mishra et al. Frontiers in Immunology
- Pitfalls in the Diagnosis of Nodular Lymphocyte Predominant Hodgkin Lymphoma: Variant Patterns, Borderlines and Mimics
- (2021) Sheren Younes et al. Cancers
- TCR-induced FOXP3 expression by CD8+ T cells impairs their anti-tumor activity
- (2021) Teresa Lozano et al. CANCER LETTERS
- Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma
- (2019) Sven Borchmann et al. BLOOD
- Diagnostic utility of STAT6YE361 expression in classical Hodgkin lymphoma and related entities
- (2019) Charles Van Slambrouck et al. MODERN PATHOLOGY
- Programmed death-1 ligands PD-L1 and PD-L2 show distinctive and restricted patterns of expression in lymphoma subtypes
- (2018) Poonam K. Panjwani et al. HUMAN PATHOLOGY
- PD1hi cells associate with clusters of proliferating B-cells in marginal zone lymphoma
- (2018) Katherine Wickenden et al. Diagnostic Pathology
- JUNB, DUSP2, SGK1, SOCS1 and CREBBP are frequently mutated in T-cell/histiocyte rich large B-cell lymphoma
- (2018) Bianca Schuhmacher et al. HAEMATOLOGICA
- Coupling of Polo kinase activation to nuclear localization by a bifunctional NLS is required during mitotic entry
- (2017) David Kachaner et al. Nature Communications
- Polo-like-kinase 1 (PLK-1) and c-myc inhibition with the dual kinase-bromodomain inhibitor volasertib in aggressive lymphomas
- (2017) Carlos Murga-Zamalloa et al. Oncotarget
- SUMOylation Promotes Nuclear Import and Stabilization of Polo-like Kinase 1 to Support Its Mitotic Function
- (2017) Donghua Wen et al. Cell Reports
- Follicular Helper T Cells
- (2016) Carola G. Vinuesa et al. Annual Review of Immunology
- Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institution
- (2016) S. S. Kenderian et al. BLOOD
- A strong host response and lack of MYC expression are characteristic for diffuse large B cell lymphoma transformed from nodular lymphocyte predominant Hodgkin lymphoma
- (2016) Bianca Schuhmacher et al. Oncotarget
- Array comparative genomic hybridization reveals similarities between nodular lymphocyte predominant Hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma
- (2015) Sylvia Hartmann et al. BRITISH JOURNAL OF HAEMATOLOGY
- Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective study
- (2015) J. Lazarovici et al. HAEMATOLOGICA
- Long-Term Course of Patients With Stage IA Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the German Hodgkin Study Group
- (2015) Dennis A. Eichenauer et al. JOURNAL OF CLINICAL ONCOLOGY
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
- (2015) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 expression defines two distinct T-cell sub-populations in follicular lymphoma that differentially impact patient survival
- (2015) Z -Z Yang et al. Blood Cancer Journal
- Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective study
- (2015) J. Lazarovici et al. HAEMATOLOGICA
- Consensus nomenclature for CD8+T cell phenotypes in cancer
- (2015) Lionel Apetoh et al. OncoImmunology
- Spatial Separation of Plk1 Phosphorylation and Activity
- (2015) Wytse Bruinsma et al. Frontiers in Oncology
- Advanced-stage nodular lymphocyte predominant Hodgkin lymphoma compared with classical Hodgkin lymphoma: a matched pair outcome analysis
- (2014) K. H. Xing et al. BLOOD
- PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors
- (2014) Alena Gros et al. JOURNAL OF CLINICAL INVESTIGATION
- A simplified scoring system to document variant patterns in nodular lymphocyte predominant Hodgkin lymphoma
- (2014) Tanuja Shet et al. LEUKEMIA & LYMPHOMA
- The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)
- (2013) S. Hartmann et al. BLOOD
- Intranodular clusters of activated cells with T follicular helper phenotype in nodular lymphocyte predominant Hodgkin lymphoma: a pilot study of 32 cases from Finland
- (2013) Bharat N. Nathwani et al. HUMAN PATHOLOGY
- Nodular Lymphocyte Predominant Hodgkin Lymphoma and T Cell/Histiocyte Rich Large B Cell Lymphoma - Endpoints of a Spectrum of One Disease?
- (2013) Sylvia Hartmann et al. PLoS One
- The density of CD8+ T-cell infiltration and expression of BCL2 predicts outcome of primary diffuse large B-cell lymphoma of bone
- (2013) Hajnalka Rajnai et al. VIRCHOWS ARCHIV
- Inhibitory Receptor Expression Depends More Dominantly on Differentiation and Activation than “Exhaustion” of Human CD8 T Cells
- (2013) Amandine Legat et al. Frontiers in Immunology
- Foxp3+ follicular regulatory T cells control the germinal center response
- (2011) Michelle A Linterman et al. NATURE MEDICINE
- T cell/histiocyte-rich large B-cell lymphoma: an update on its biology and classification
- (2011) Thomas Tousseyn et al. VIRCHOWS ARCHIV
- How to obtain the P value from a confidence interval
- (2011) D. G. Altman et al. BMJ-British Medical Journal
- CD8+Foxp3+ tumor infiltrating lymphocytes accumulate in the context of an effective anti-tumor response
- (2010) Dung T. Le et al. INTERNATIONAL JOURNAL OF CANCER
- Immunity to Murine Prostatic Tumors: Continuous Provision of T-Cell Help Prevents CD8 T-Cell Tolerance and Activates Tumor-Infiltrating Dendritic Cells
- (2009) K. A. Shafer-Weaver et al. CANCER RESEARCH
- Increased programmed death-1+ tumor-infiltrating lymphocytes in classical Hodgkin lymphoma substantiate reduced overall survival
- (2009) Simone Muenst et al. HUMAN PATHOLOGY
- Cutting Edge: Tumor-Specific CD8+ T Cells Infiltrating Prostatic Tumors Are Induced to Become Suppressor Cells
- (2009) K. A. Shafer-Weaver et al. JOURNAL OF IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation